Dual pathway inhibition as compared to acetylsalicylic acid monotherapy in relation to endothelial function in peripheral artery disease, a phase iv clinical trial

HIGHLIGHTS

• who: Loes H. Willems from the Osaka University, Japan have published the research: Dual pathway inhibition as compared to acetylsalicylic acid monotherapy in relation to endothelial function in peripheral artery disease, a phase IV clinical trial, in the Journal: (JOURNAL)
• what: The authors investigated the potential impact of switching ASA monotherapy to DPI, by combining ASA with low-dose rivaroxaban, on macro- and microvascular endothelial dysfunction in patients with PAD and observed no differences.
• how: The study was conducted in accordance with the latest revision of the Declaration of Helsinki and Good Clinical . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.